nach oben

European Journal of Epidemiology

Erschienen in:

01.07.2013 | Letter to the Editor

Circulating 25-hydroxyvitamin D levels and hypertension risk

verfasst von: Yili Wu, Shiru Li, Dongfeng Zhang

Erschienen in: European Journal of Epidemiology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Excerpt

We read with great interest the meta-analysis by Kunutsor et al. [1] on vitamin D status [circulating 25-hydroxyvitamin D 25((OH) D) levels and dietary vitamin D intake] and risk of hypertension. The results showed that the pooled relative risk (RR) of hypertension was 0.70 [95 % confidence interval (CI): 0.58–0.86] for the highest versus the lowest category of circulating 25(OH) D levels with 7 prospective studies from 6 articles (48,633 participants and 4,965 cases). In addition, the risk of hypertension decreased by 12 % [RR (95 % CI): 0.88 (0.81–0.97)] for every per 10 ng/ml increment in circulating 25(OH) D levels when assuming a linear dose–response relationship with 5 prospective studies from 4 articles. This is a very important investigation because there are conflicting results with regard to the association of circulating 25(OH) D levels with hypertension risk. In this letter, we would like to draw attention to the following three aspects: …

Nur mit Berechtigung zugänglich

Kunutsor SK, Apekey TA, Steur M (2013) Vitamin D and risk of future hypertension: meta-analysis of 283,537 participants. Eur J Epidemiol. 2013;28(3):205–21.

Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73.PubMedCrossRef

Bhandari SK, Pashayan S, Liu IL, Rasgon SA, Kujubu DA, Tom TY, et al. 25-hydroxyvitamin D levels and hypertension rates. J Clin Hypertens (Greenwich). 2011;13(3):170–7.CrossRef

Khader YS, Batieha A, Jaddou H, Batieha Z, El-Khateeb M, Ajlouni K. Relationship between 25-hydroxyvitamin D and metabolic syndrome among Jordanian adults. Nutr Res Pract. 2011;5(2):132–9.PubMedCrossRef

Pacifico L, Anania C, Osborn JF, Ferraro F, Bonci E, Olivero E, et al. Low 25(OH)D3 levels are associated with total adiposity, metabolic syndrome, and hypertension in Caucasian children and adolescents. Eur J Endocrinol. 2011;165(4):603–11.PubMedCrossRef

Caro Y, Negron V, Palacios C. Association between vitamin D levels and blood pressure in a group of Puerto Ricans. P R Health Sci J. 2012;31(3):123–9.PubMed

Dorjgochoo T, Ou Shu X, Xiang YB, Yang G, Cai Q, Li H, et al. Circulating 25-hydroxyvitamin D levels in relation to blood pressure parameters and hypertension in the Shanghai Women’s and Men’s Health Studies. Br J Nutr. 2012;108(3):449–58.PubMedCrossRef

Kim S, Lim J, Kye S, Joung H. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and Nutrition Examination Survey IV-2, 2008. Diabetes Res Clin Pract. 2012;96(2):230–6.PubMedCrossRef

Lee SH, Kim SM, Park HS, Choi KM, Cho GJ, Ko BJ et al. (2012) Serum 25-hydroxyvitamin D levels, obesity and the metabolic syndrome among Korean children. Nutr Metab Cardiovasc Dis. doi:10.1016/j.numecd.2012.04.013.

10.

Li L, Yin X, Yao C, Zhu X, Wu X. Vitamin D, parathyroid hormone and their associations with hypertension in a Chinese population. PLoS ONE. 2012;7(8):e43344.

11.

Nam GE, Kim DH, Cho KH, Park YG, Han KD, Kim SM et al. (2012) 25-Hydroxyvitamin D insufficiency is associated with cardiometabolic risk in Korean adolescents: the 2008-2009 Korea National Health and Nutrition Examination Survey (KNHANES). Public Health Nutr. 1–9. doi:10.1017/S1368980012004855.

12.

Park HY, Lim YH, Kim JH, Bae S, Oh SY, Hong YC. Association of serum 25-hydroxyvitamin D levels with markers for metabolic syndrome in the elderly: a repeated measure analysis. J Korean Med Sci. 2012;27(6):653–60.PubMedCrossRef

13.

Sumriddetchkajorn K, Chailurkit L, Thakkinstian A, Sritara P. Hypertension is statistically associated with higher body mass index but not with vitamin D level in a Thai population. Eur J Clin Nutr. 2012;66(3):405–7.PubMedCrossRef

14.

Wang L, Ma J, Manson JE, Buring JE, Gaziano JM, Sesso HD (2012) A prospective study of plasma vitamin D metabolites, vitamin D receptor gene polymorphisms, and risk of hypertension in men. Eur J Nutr. doi:10.1007/s00394-012-0480-8.

15.

Burgaz A, Orsini N, Larsson SC, Wolk A (2011) Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens 29(4):636–5.

Titel: Circulating 25-hydroxyvitamin D levels and hypertension risk
verfasst von: Yili Wu
Shiru Li
Dongfeng Zhang
Publikationsdatum: 01.07.2013
Verlag: Springer Netherlands
Erschienen in: European Journal of Epidemiology / Ausgabe 7/2013
Print ISSN: 0393-2990
Elektronische ISSN: 1573-7284
DOI: https://doi.org/10.1007/s10654-013-9817-8

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2013

Serum calcium and the calcium-sensing receptor polymorphism rs17251221 in relation to coronary heart disease, type 2 diabetes, cancer and mortality: the Tromsø Study

Competing risk bias to explain the inverse relationship between smoking and malignant melanoma

Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study

Risk categorization for calculating net reclassification improvement

A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases

Better risk assessment with glycated hemoglobin instead of cholesterol in CVD risk prediction charts